Table 3.

Medians of Continuous Variables by TEL-AML1

Variable TEL-AML1
Not Tested Negative Positive Overall
N  262 101  32  395  
Age at initial diagnosis (mo)* 60  74 53.5  63  
Age at relapse diagnosis (mo)  105  124 111.5  111  
Duration of last remission (mo) 29  27 42.5  29  
Log10 (peripheral blast cell count [1/μL] + 1)  2.56  2.52  2.87  2.54 
Log10 (WBC count [1/μL] + 1)  3.77  3.79 3.75  3.77  
Observation time (mo) 49  21  21.5 38 
Variable TEL-AML1
Not Tested Negative Positive Overall
N  262 101  32  395  
Age at initial diagnosis (mo)* 60  74 53.5  63  
Age at relapse diagnosis (mo)  105  124 111.5  111  
Duration of last remission (mo) 29  27 42.5  29  
Log10 (peripheral blast cell count [1/μL] + 1)  2.56  2.52  2.87  2.54 
Log10 (WBC count [1/μL] + 1)  3.77  3.79 3.75  3.77  
Observation time (mo) 49  21  21.5 38 

Significant difference between groups as assessed by Wilcoxon rank-sum test: *between TEL-AML1–positive and –negative, Z = −2.21336, P > ‖Z‖ = .0269; †betweenTEL-AML1– positive and –negative, Z = 4.35458, P > ‖Z‖ = .0001; ‡between tested and not tested, Z = −11.0831, P > ‖Z‖ = .0001.

or Create an Account

Close Modal
Close Modal